ALung Technologies

ALung Technologies

A medical device company for patients with respiratory failure. Developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation.

Edit ID  15657115 

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 30 Mar, 2020
Edits made to:
Article (+13/-13 characters)

ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United StatesUnited States law to investigational use. ALung is conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.